Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.38 USD | -1.60% | -2.45% | -25.75% |
Composition of Kelly Strategic CRISPR & Gene Editing Technology ETF - USD
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| ||
---|---|---|---|---|---|---|
568 USD | +0.93% | -2.75% | +7.01% | 11.69% | ||
21.38 USD | -3.26% | -13.93% | -29.88% | 11.15% | ||
53.74 USD | -0.59% | -2.72% | -14.15% | 8.55% | ||
23.81 USD | -1.16% | -2.10% | -12.53% | 8.03% | ||
2.88 USD | +1.05% | -3.03% | -49.74% | 6.97% | ||
2.99 USD | +3.10% | +0.67% | -11.01% | 4.87% | ||
5.2 USD | +0.58% | -7.64% | -48.67% | 4.83% | ||
161.2 USD | +3.15% | +2.66% | +4.05% | 4.81% | ||
6.48 USD | -0.31% | -6.43% | -26.86% | 4.71% | ||
5.19 USD | +0.97% | -1.70% | -62.77% | 4.13% | ||
93.17 CHF | +2.13% | +1.56% | +9.78% | 3.79% | ||
0.5644 USD | +3.52% | -5.17% | +3.88% | 3.66% | ||
2.5 USD | +1.63% | -0.79% | -22.12% | 3.54% | ||
130.4 USD | -0.77% | -13.44% | -6.20% | 2.57% | ||
41.12 USD | +2.17% | -0.28% | -19.85% | 2.37% | ||
4.22 USD | -3.21% | -6.43% | -1.17% | 2.23% | ||
89.76 EUR | +1.34% | +0.27% | -.--% | 2.20% | ||
104.3 USD | +3.20% | -2.07% | -25.11% | 1.77% | ||
455.3 USD | +2.77% | -0.35% | +11.91% | 1.71% | ||
980.2 USD | +1.06% | -0.49% | +11.60% | 1.62% | ||
224.9 USD | +2.21% | +3.27% | -13.07% | 0.65% | ||
Description
US48817R7061 | |
---|---|
Total Expense Ratio | 0.78% |
Asset Class | |
Sector | |
Size | |
Currency | |
Provider | |
Underlying | Strategic CRISPR & Gene Editing Technology Index NR - USD |
Features and characteristics
Jurisdiction | |
Replication Method | |
Replication Model | |
Date of creation |
2022-01-11
|
Dividend Policy | |
Geographical Focus |
AuM evolution ( 2023-10-30 )
AuM (EUR) | 2 M€ |
---|---|
AuM 1M | 2 M€ |
AuM 3 months | 2 M€ |
AuM 6 months | 2 M€ |
AuM 12 months | 5 M€ |
- Stock Market
- ETF
- XDNA ETF
- Components Kelly Strategic CRISPR & Gene Editing Technology ETF - USD